Product image of Nexazole (Esomeprazole) supplied by GNH India

Nexazole

Active Ingredient:
Esomeprazole
Origin:
EU

Nexazole (Esomeprazole)

Esomeprazole, the active ingredient in Nexazole, is a Proton Pump Inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, and peptic ulcer disease in adult patients.

GNH India supplies Nexazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Manufacturer / TM Owner

Pinewood Laboratories Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nexazole (esomeprazole) is indicated for several acid‑related conditions where suppression of gastric acid is required.

  • Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH.
  • Erosive esophagitis: promotes healing of inflamed esophageal mucosa.
  • Peptic ulcer disease: supports ulcer resolution and symptom control.
  • NSAID‑induced gastric ulcer prevention: reduces risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.
  • Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens for H. pylori infection.

How It Works

  • Esomeprazole is the S‑isomer of omeprazole that selectively and irreversibly binds to the cysteine residues of the gastric H⁺/K⁺‑ATPase (proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly decreases both basal and stimulated gastric acid output, leading to an elevated intragastric pH and facilitating mucosal healing.

Side Effects

Like all medications, esomeprazole may cause adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: watery stools, usually transient.
  • Abdominal pain: discomfort or cramping in the stomach area.
  • Nausea: feeling of unease or urge to vomit.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis with diarrhea.
  • Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty.
  • Stevens‑Johnson syndrome/toxic epidermal necrolysis: skin blistering and detachment.
  • Hypomagnesemia: low serum magnesium with muscle cramps or arrhythmias.
  • Vitamin B12 deficiency: anemia and neurological symptoms with long‑term use.
  • Increased risk of bone fractures: especially with prolonged therapy.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Assess renal function: adjust use in severe renal impairment.
  • Use with caution in elderly: monitor for increased fracture risk.
  • Avoid prolonged therapy without supervision: long‑term use may lead to nutrient deficiencies.
  • Monitor for drug‑induced hypomagnesemia: check serum magnesium periodically.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Esomeprazole can affect the pharmacokinetics of several co‑administered medicines; interactions are classified by clinical significance.

Major Interactions (Avoid)

  • Ketoconazole: reduced antifungal absorption.
  • Atazanavir: decreased antiviral efficacy.
  • Clopidogrel: impaired antiplatelet activation.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible alteration of INR.
  • Digoxin: increased serum concentrations.
  • Methotrexate: heightened toxicity risk.

Frequently Asked Questions

Nexazole contains esomeprazole and is prescribed for acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, peptic ulcer disease, prevention of NSAID‑induced gastric ulcers, and as part of combination therapy for Helicobacter pylori eradication.

Esomeprazole selectively and irreversibly inhibits the gastric H⁺/K⁺‑ATPase (proton pump) on parietal cells, blocking the final step of acid secretion. This reduces both basal and stimulated gastric acid output, raising stomach pH and allowing damaged mucosa to heal.

The appropriate dose of Nexazole is determined by the prescribing clinician based on the specific indication, patient characteristics, and treatment duration. Dosage regimens may vary, and the prescriber will provide individualized instructions.

Safety data for esomeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Nexazole, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nexazole (esomeprazole) is the S‑enantiomer of omeprazole, offering more consistent plasma concentrations and potentially improved acid control. Compared with other PPIs, it has a similar efficacy profile but may provide a slightly faster onset of action and reduced inter‑patient variability.

Nexazole should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency.

Nexazole is taken orally, usually as a whole tablet swallowed with water. It may be taken with or without food, but consistency with respect to meals helps maintain steady drug levels. Follow the prescriber’s instructions for timing and frequency.

Serious adverse events, although rare, include Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, persistent low magnesium levels, and long‑term vitamin B12 deficiency which can lead to anemia and neuropathy.

Patients with known hypersensitivity to esomeprazole, other PPIs, or any component of the formulation should avoid Nexazole. Caution is also advised for individuals with severe liver disease, and it is contraindicated in those with a documented allergy to the drug.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Esomeprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT